AHCO
AdaptHealth Corp.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 26 to Feb 27 ▲ 2 days of insider buys: $116.2K by 2 insiders, avg $8.94
- Mar 10 to Mar 20 ▲ 5 days of insider buys: $48.7M by 2 insiders, avg $9.76
- Apr 13 ▲ AdaptHealth refinanced its senior secured credit facility, terminati…
- Jun 1 ▼ 1 insider sell $113.4K at $10.06
- Jul 1 ▼ 1 insider sell $117.7K at $10.44
- Jul 2 ▼ AdaptHealth disclosed a material cybersecurity incident involving un…
- Jul 21 ▲ Jefferies upgrades
- Aug 6 to Aug 7 ▲ 2 days of insider buys: $393.1K by 2 insiders, avg $6.19
- Aug 31 ▼ Short interest jumps 36.7% to 10.39M
- Oct 29 (PS) Pete v. Adapthealth Corp.
- Nov 3 ▼ Earnings: AHCO Q3 2026 Earnings: EPS $-0.13 (-1192.4% vs est)
- Nov 3 AdaptHealth reported Q3 2026 revenue of $745.6M (+10.9% YoY), above…
Signal stack
Where each data set points today.
- InsidersBULLISH
5 insiders bought $49.2M at an average $9.71. 1 insider sold $231.1K. Price is 20% below their cost.
- InstitutionsBULLISH
Q3 2026: 39 added (0 new), 18 trimmed or exited.
- AnalystsBULLISH
12 of 13 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest +6.8% to 10.93M shares. 5.2 days to cover, ≈8.0% of shares.
- TrendUPTREND
25% above its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $61.0M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | TRIM | $21.8M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $18.1M |
| UBS Group AG | DOUBLED | $4.0M |
| CITIGROUP INC | DOUBLED | $2.8M |
| FIRST TRUST ADVISORS LP | ADD | $2.5M |
| Nuveen, LLC | ADD | $2.2M |
| Vanguard Global Advisers, LLC | ADD | $1.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
13 analystsPrice is below the lowest target. Median implies +16%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 5, 2026 | Leerink Partners MAINTAIN | Outperform |
| Nov 4, 2026 | UBS MAINTAIN | Buy |
| Sep 17, 2026 | Baird MAINTAIN | Outperform |
| Aug 6, 2026 | UBS MAINTAIN | Buy |
| Aug 6, 2026 | RBC Capital MAINTAIN | Outperform |
| Aug 5, 2026 | Truist Securities MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
CURRIE HARRISS T CHIEF FINANCIAL OFFICER Sep 9, 2026 | AWARD | 141,372 sh |
WOLF DALE B Director Aug 7, 2026 | BUY | $117.2K |
SAMET KENNETH A Director Aug 6, 2026 | BUY | $149.9K |
WOLF DALE B Director Aug 6, 2026 | BUY | $126.0K |
Schuster III Russell E. Chief Commercial Officer Jul 1, 2026 | SELL | $117.7K |
BELINFANTI GREGORY Director Jun 24, 2026 | AWARD | 18,999 sh |
Connors Terence J Director Jun 24, 2026 | AWARD | 18,999 sh |
Williams David Solomon III Director Jun 24, 2026 | AWARD | 18,999 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.09 | -$0.13–-$0.07 | +0.0% | $720.5M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 3 bullish · 4 bearish · 2 mixed · 11 neutral- NEUTRAL 144Nov 16, 2026
Former CFO Jason A. Clemens filed a Form 144 notice of intent to sell 10,383 shares of AdaptHealth Corp. common stock, valued at approximately $82,239 based on the filing date price. The shares were acquired via restricted stock vesting under a registered plan on October 1, 2022.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 144Nov 13, 2026
Former CFO Jason A. Clemens filed a Form 144 notice of intent to sell 10,000 shares of AdaptHealth…
The Form 144 is an intent to sell; the sale may not occur. However, the former CFO has already sold ~$1.86M in shares over the prior week, suggesting ongoing portfolio liquidation. Monitor for any…
- NEUTRAL 144Nov 12, 2026
Jason A. Clemens, former CFO of AdaptHealth Corp., filed a Form 144 notice to sell 19,855 shares…
The former CFO's sales are substantial in absolute dollar terms but represent a small fraction of the company's market cap. The sales follow restricted stock vesting, which is routine for departing…
- NEUTRAL INST-CLUSTERNov 9, 2026
11 institutional buyers accumulated $5.1M in net new AHCO positions during Q3 2026, while 2…
The cluster is small in dollar terms and dominated by asset managers doubling tiny positions, suggesting low conviction. The largest seller (Russell Investments) exited a meaningful stake. Monitor…
All AHCO filing & press-release reports (20)
- 144 reportNov 16, 2026
- 144 reportNov 13, 2026
- 144 reportNov 12, 2026
- INST-CLUSTER reportNov 9, 2026
- 144 reportNov 6, 2026
- 144 reportNov 5, 2026
- SC 13G/A reportNov 5, 2026
- 8-K reportNov 3, 2026
- COURT-RULING reportOct 29, 2026
- SC 13G/A reportOct 13, 2026
- SC 13G/A reportOct 8, 2026
- INST-CLUSTER reportAug 15, 2026
- CLUSTER reportAug 14, 2026
- CLUSTER reportAug 10, 2026
- 8-K reportJul 2, 2026
- 3 reportJun 26, 2026
- 8-K reportMay 5, 2026
- CLUSTER reportMar 12, 2026
- 8-K reportApr 13, 2026
- CLUSTER reportFeb 26, 2026